Loading company…
Basel-based biotechnology firm developing RNA therapeutics for rare genetic disorders, cancer and infectious diseases.
Founded in 2017 and based in Basel, Switzerland, Versameb AG was established by Friedrich Metzger and Norbert Bleich and is led by CEO Klaas Zuideveld. The company develops RNA therapeutics for rare genetic disorders, cancer and infectious diseases, earning revenue from partnerships and fee-for-service research agreements. It raised CHF 6 million in a Seed round in July 2020.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in